S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 40 of 72

Issue Date	Title / Author(s) / Citation	File
2007-12	Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival Yun, Young Ho; Park, Sang Min; Noh, Dong Young; Nam, Seok Jin; Ahn, Se Hyun; Park, Byeong Woo; Lee, Eun Sook BREAST CANCER RESEARCH AND TREATMENT Vol.106 No.2, pp. 245-253	DOI
2008-03	Association of clinical experiences with patient-reported outcomes among breast cancer surgery patients: breast cancer quality care study Noh, Dong Young; Nam, Seok Jin; Ahn, Se Hyun; Park, Byeong Woo; Lee, Eun Sook; Lee, Myung Kyung; Kim, Soo Hyun; Kim, Yoo Min; Park, Sang Min; Yun, Young Ho QUALITY OF LIFE RESEARCH Vol.17 No.2, pp. 215-225	DOI
2009-03	Weight changes after adjuvant treatment in Korean women with early breast cancer Han, Hye-Suk; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Sung-Won; Kim, In-Ah; Oh, Do-Youn; Im, Seock-Ah; Bang, Soo-Mee; Lee, Jong Seok Breast Cancer Research and Treatment, Vol.114 No.1, pp.147-153	DOI
2009-04	Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC) Lee, Sang Gyu; Jee, Young Geon; Chung, Hyun Chul; Kim, Sung-Bae; Ro, Jungsil; Im, Young-Hyuck; Im, Seock-Ah; Seo, Jae Hong Breast Cancer Research and Treatment, Vol.114 No.3, pp.589-595	DOI
2009-07	Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Cho, Nariya; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue Breast Cancer Research and Treatment, Vol.116 No.1, pp.153-160	DOI
2011-01	High serum TGF-alpha predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer Rhee, Jiyoung; Han, Sae-Won; Cha, Yongjun; Ham, Hye Seon; Kim, Hwang-phill; Oh, Do-Youn; Im, Seock-Ah; Park, Jong-Wan; Ro, Jungsil; Lee, Keun Seok; Park, In Hae; Im, Young-Hyuck; Bang, Yung-Jue; Kim, Tae-You Breast Cancer Research and Treatment, Vol.125 No.1, pp.107-114	DOI
2011-01	Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01) Kim, Jeong Eun; Ahn, Jin-Hee; Jung, Kyung Hae; Kim, Sung-Bae; Kim, Hwa Jung; Lee, Keun-Suk; Ro, Jung-Sil; Park, Yun-Hee; Ahn, Jin-Suk; Im, Young-Hyk; Im, Seock-Ah; Lee, Moon-Hee; Kim, Si-Young Breast Cancer Research and Treatment, Vol.125 No.1, pp.99-106	DOI
2011-02	Utility of partial volume-corrected FDG PET/CT for axillary nodal staging in patients with breast cancer 이효상	link
2011-02	Comparison of apparent diffusion coefficient (ADC) value of the breast cancers Using 2D and 3D Data 윤보라	link
2011-02	유방암에서 암 줄기세포 표지자와 상피-간엽 전환 표지자 발현의 임상병리학적 의의 최유미	link
2011-08	Mucin 1 (Muc 1) oncoprotein regulates the tumor angiogenic response by VEGF production 우종규	link
2011-09	Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Park, Sohee; Nam, Byung-Ho; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Journal of Cancer Research and Clinical Oncology, Vol.137 No.9, pp.1301-1308	DOI
2012-01	Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer Park, Sang Hee; Moon, Woo Kyung; Cho, Nariya; Chang, Jung Min; Im, Seock-Ah; Park, In Ae; Kang, Keon Wook; Han, Wonshik; Noh, Dong-Young European Radiology, Vol.22 No.1, pp.18-25	DOI
2012-04	Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients Choi, Hei Kyung; Cho, Nariya; Moon, Woo Kyung; Im, Seock-Ah; Han, Wonshik; Noh, Dong-Young European Journal of Radiology, Vol.81 No.4, pp.737-743	DOI
2012-08	Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy Distinct patterns of response according to ER expression Moon, Hyeong-Gon; Im, Seock-Ah; Han, Wonshik; Oh, Do-Youn; Han, Sae-Won; Keam, Bhumsuk; Park, In Ae; Chang, Jung Min; Moon, Woo Kyung; Cho, Nariya; Noh, Dong-Young Breast Cancer Research and Treatment, Vol.134 No.3, pp.1133-1140	DOI
2013-02	In Vivo and Ex Vivo Elasticity Measurements of Human Breast Cancers 이수현	view file
2013-02	Effect of short message service as a reminder for breast self-examination in breast cancer patients 정일용	view file
2013-04	Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Koh, Youngil; Han, Sae-Won; Oh, Do-Youn; Cho, Nariya; Kim, Jee Hyun; Han, Wonshik; Kang, Keon Wook; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Chung, June-Key; Bang, Yung-Jue Breast Cancer, Vol.20 No.2, pp.167-173	DOI
2013-07	HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.1, pp.109-115	DOI
2013-11	Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jin-Soo; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.5, pp.1023-1029	DOI
2014-03	Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy Lee, Soo-Youn; Im, Seock-Ah; Park, Yeon Hee; Woo, Sook Young; Kim, Seonwoo; Choi, Moon Ki; Chang, Wonjin; Ahn, Jin Seok; Im, Young-Hyuck European Journal of Cancer, Vol.50 No.4, pp.698-705	DOI
2014-07	Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy Lee, Hyun Jung; Kim, Dae Young; Keam, Bhumsuk; Lee, Jeong Hoon; Han, Sae-Won; Oh, Do-Youn; Yoon, Jung Hwan; Kim, Tae-You; Kim, Yu Jung; Lee, Keun Wook; Kim, Jin-Wook; Jeong, Sook-Hyang; Lee, Jong Seok; Kim, Jee Hyun; Im, Seock-Ah Breast Cancer, Vol.21 No.4, pp.387-393	DOI
2014-07	Low Adherence to Upfront and Extended Adjuvant Letrozole Therapy among Early Breast Cancer Patients in a Clinical Practice Setting Lee, Hye-Suk; Lee, Ju-Yeun; Ah, Young-Mi; Kim, Hyang-Sook; Im, Seock-Ah; Noh, Dong-Young; Lee, Byung Koo Oncology, Vol.86 No.5-6, pp.340-349	DOI
2014-08	Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial Kim, Sung-Bae; Yoo, Changhoon; Ro, Jungsil; Im, Seock-Ah; Im, Young-Hyuck; Kim, Jee Hyun; Ahn, Jin-Hee; Jung, Kyung Hae; Song, Hong Suk; Kang, Seok Yun; Park, Hee Sook; Chung, Hyun-Cheol Investigational New Drugs, Vol.32 No.4, pp.753-761	DOI
2014-08	Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer Cha, Yongjun; Han, Sae-Won; Seol, Hyesil; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, In Ae; Han, Wonshik; Noh, Dong-Young; Kim, Tae-You Anticancer Research, Vol.34 No.8, pp.4275-4280
2015-02	Assessment of HER2 status in invasive breast cancer with increased centromere 17 copy number by fluorescence in situ hybridization 장민혜	view file
2015-02	A histomorphologic predictive model for axillary lymph node metastasis in preoperative breast cancer core needle biopsy according to intrinsic subtypes Yoo, Su Hyun; Park, In Ae; Chung, Yul Ri; Kim, Hyojin; Lee, Keehwan; Noh, Dong-Young; Im, Seock-Ah; Han, Wonshik; Moon, Hyeong-Gon; Lee, Kyung-Hun; Ryu, Han Suk Human Pathology, Vol.46 No.2, pp.246-254	DOI
2015-07	Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02) Park, Yeon Hee; Jung, Kyung Hae; Im, Seock-Ah; Sohn, Joo Hyuk; Ro, Jungsil; Ahn, Jin-Hee; Kim, Sung-Bae; Nam, Byung-Ho; Oh, Do Youn; Han, Sae-Won; Lee, Soohyeon; Park, In Hae; Lee, Keun Seok; Kim, Jee Hyun; Kang, Seok Yun; Lee, Moon Hee; Park, Hee Sook; Woo, Sook Young; Jung, Sin-Ho; Ahn, Jin Seok; Im, Young-Hyuck Breast Cancer Research and Treatment, Vol.152 No.1, pp.77-85	DOI
2015-07	Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype Chung, Yul Ri; Kim, Hyojin; Park, Soo Young; Park, In Ae; Jang, Ja June; Choe, Ji-Young; Jung, Yoon Yang; Im, Seock-Ah; Moon, Hyeong-Gon; Lee, Kyung-Hun; Suh, Koung Jin; Kim, Tae-Yong; Noh, Dong-Young; Han, Wonshik; Ryu, Han Suk Human Pathology, Vol.46 No.7, pp.1027-1035	DOI
2015-08	Recurrent Fusion Transcripts Detected by Whole-transcriptome Sequencing of 120 Primary Breast Cancer Samples 김지선, 김세환, 고세윤, 인용호, 문형곤, 안수경, 김민균, 이민주, 황진하, 주영석, 김종일, 노동영, 김선, 박정훈, 이환석, 김성훈, 한원식	view file
2015-11	Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer Kim, Hyojin; Lee, Kyung-Hun; Park, In Ae; Chung, Yul Ri; Im, Seock-Ah; Noh, Dong-Young; Han, Wonshik; Moon, Hyeong-Gon; Jung, Yoon Yang; Ryu, Han Suk Virchows Archiv, Vol.467 No.5, pp.563-570	DOI
2016-01	Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer Kim, Ji-Won; Kim, Debora K.; Min, Ahrum; Lee, Kyung-Hun; Nam, Hyun-Jin; Kim, Jee Hyun; Kim, Jin-Soo; Kim, Tae-Yong; Im, Seock-Ah; Park, In Ae Journal of Cancer Research and Clinical Oncology, Vol.142 No.1, pp.157-165	DOI
2016-03	Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy Kim, Hyori; Youk, Jeonghwan; Yang, Yaewon; Kim, Tae-Yong; Min, Ahrum; Ham, Hye-Seon; Cho, Seongcheol; Lee, Kyung-Hun; Keam, Bhumsuk; Han, Sae-Won; Oh, Do-Youn; Ryu, Han Suk; Han, Wonshik; Park, In Ae; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Journal of Cancer Research and Clinical Oncology, Vol.142 No.3, pp.707-714	DOI
2016-04	A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09 Lee, Ki Hyeong; Kim, Ji-Yeon; Lee, Moon Hee; Han, Hye Sook; Lim, Joo Han; Park, Keon Uk; Park, In Hae; Cho, Eun Kyung; Yoon, So Young; Kim, Jee Hyun; Choi, In Sil; Park, Jae Hoo; Choi, Young Jin; Kim, Hee-Jun; Jung, Kyung Hae; Kim, Si-Young; Oh, Do-Youn; Im, Seock-Ah Supportive Care in Cancer, Vol.24 No.4, pp.1709-1717	DOI
2016-05	The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): Study protocol for a randomized controlled trial and progress Kim, Hyun-Ah; Ahn, Sei Hyun; Nam, Seok Jin; Park, Seho; Ro, Jungsil; Im, Seock-Ah; Jung, Yong Sik; Yoon, Jung Han; Hur, Min Hee; Choi, Yoon Ji; Lee, Soo-Jung; Jeong, Joon; Cho, Se-Heon; Kim, Sung Yong; Lee, Min Hyuk; Kim, Lee Su; Moon, Byung-In; Kim, Tae Hyun; Park, Chanheun; Kim, Sei Joong; Jung, Sung Hoo; Park, Heungkyu; Gwak, Geum Hee; Kang, Sun Hee; Kim, Jong Gin; Kim, Jeryong; Choi, Su Yun; Lim, Cheol-Wan; Kim, Doyil; Yoo, Youngbum; Song, Young-Jin; Kang, Yoon-Jung; Jung, Sang Seol; Shin, Hyuk Jai; Lee, Kwan Ju; Han, Se-Hwan; Lee, Eun Sook; Han, Wonshik; Kim, Hee-Jung; Noh, Woo Chul BMC Cancer, Vol.16, p. 319	DOI
2016-08	Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer Lee, Su Hyun; Ha, Seunggyun; An, Hyun Joon; Lee, Jae Sung; Han, Wonshik; Im, Seock-Ah; Ryu, Han Suk; Kim, Won Hwa; Chang, Jung Min; Cho, Nariya; Moon, Woo Kyung; Cheon, Gi Jeong European Journal of Nuclear Medicine and Molecular Imaging, Vol.43 No.9, pp.1574-1584	DOI
2017-04	Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer Hong, A. R.; Kim, J. H.; Lee, K. H.; Kim, T. Y.; Im, S. A.; Kim, T. Y.; Moon, H. G.; Han, W. S.; Noh, D. Y.; Kim, S. W.; Shin, C. S. Osteoporosis International, Vol.28 No.4, pp.1413-1422	DOI
2017-05	Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer Lee, Kwang-Min; Jung, Doo-Young; Hwang, Heesung; Kim, Won-Hyoung; Lee, Joo-Young; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Spiegel, David; Hahm, Bong-Jin Chronobiology International, Vol.34 No.4, pp.480-491	DOI
2017-07	Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer Song, Su Jeong; Min, Ji; Suh, Sung Yun; Jung, Sun Hoi; Hahn, Hyeon Joo; Im, Seock-Ah; Lee, Ju-Yeun Supportive Care in Cancer, Vol.25 No.7, pp.2241-2248	DOI
2017-09	Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results Loibl, Sibylle; Turner, Nicholas C.; Ro, Jungsil; Cristofanilli, Massimo; Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Loi, Sherene; Andre, Fabrice; Harbeck, Nadia; Verma, Sunil; Folkerd, Elizabeth; Theall, Kathy Puyana; Hoffman, Justin; Zhang, Ke; Bartlett, Cynthia Huang; Dowsett, Mitchell Oncologist, Vol.22 No.9, pp.1028-1038	DOI

1 2